Lightheadedness may be more pronounced during the initial weeks of tirzepatide therapy or following dose escalation
Official Details: Medication: Tirzepatide (identical to Mounjaro) Manufacturer: Eli Lilly FDA Approval: November 2023 Approved For: Chronic weight management in adults with obesity or overweight with weight-related conditions Dosing: Once-weekly injection Available Doses: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg List Price: $1,069 per month (same as Mounjaro) How Zepbound Differs from Mounjaro: The medications are completely identical
An inability to pass gas or stool is a symptom of possible bowel obstruction
Maximizing Results With Weight Loss Injections Whether you choose semaglutide or tirzepatide, the injection alone wont do all the work
It is a weekly injectable GLP-1 medication
Tirzepatide regulates insulin levels and reduces appetite, offering an effective solution for weight management